February 2011 Briefing - OphthalmologyLast Updated: March 01, 2011.
Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for February 2011. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Low Pay for New Female Doctors Tied to Gender, Not Job
MONDAY, Feb. 21 (HealthDay News) -- In 2008, male physicians who were newly trained in New York State made an average of $16,819 more than newly trained female physicians, compared to a $3,600 difference in 1999, according to a study published in the February issue of Health Affairs.
Decreased Glaucoma Risk Seen in Obese Women
FRIDAY, Feb. 18 (HealthDay News) -- Obesity in women is linked to increased intraocular pressure and a reduced risk of developing open-angle glaucoma (OAG), according to a study published online Feb. 14 in the Archives of Ophthalmology.
Bevacizumab Monotherapy Effective for Infant Retinopathy
WEDNESDAY, Feb. 16 (HealthDay News) -- Bevacizumab, a vascular endothelial growth factor inhibitor, appears to be more beneficial for zone I stage 3+ retinopathy of prematurity than laser treatment, though more research is needed to determine the therapy's safety, according to research published in the Feb. 17 issue of the New England Journal of Medicine.
New U.S. Report on the Nation's Health 2010 Released
WEDNESDAY, Feb. 16 (HealthDay News) -- The U.S. Centers for Disease Control and Prevention's National Center for Health Statistics' 34th annual report, presenting the latest information on health status and determinants, utilization of health care, health care resources, expenditures, and a special feature on death and dying, was published Feb. 16.
HbA1c and Fasting Glucose Levels Predict Retinopathy
WEDNESDAY, Feb. 16 (HealthDay News) -- Hemoglobin A1c (HbA1c) and fasting plasma glucose (FPG) levels can be used as predictors for retinopathy 10 years after a baseline examination, according to a study published in the February issue of the Archives of Ophthalmology.
Most Recalled Medical Devices Given Lenient Approval
TUESDAY, Feb. 15 (HealthDay News) -- The majority of medical devices recalled from 2005 to 2009 for risk of serious health hazard or death were approved by the less strict 510(k) process intended for devices considered low or moderate risk, according to a study published online Feb. 14 in the Archives of Internal Medicine.
Researchers Explore Nature of Difficult Clinical Encounters
MONDAY, Feb. 14 (HealthDay News) -- Both patients and physicians can bring qualities to a clinical encounter that result in its being perceived as difficult, and patients involved in these types of encounters have worse short-term outcomes, according to research published online Jan. 25 in the Journal of General Internal Medicine.
One Cornea Can Be Split for Use in Two Patients
MONDAY, Feb. 14 (HealthDay News) -- A single donor cornea can be split and successfully transplanted into two recipients, according to a study published in the February issue of Ophthalmology.
Public Sector Plays Big Role in Drug Research
WEDNESDAY, Feb. 9 (HealthDay News) -- Public-sector research institutions (PSRIs) appear to play a bigger role in drug discovery than was previously thought, contributing to the discovery of about 10 to 20 percent of drugs approved for new drug applications since 1990, according to research published in the Feb. 10 issue of the New England Journal of Medicine.
|Previous: February 2011 Briefing - Hematology & Oncology||Next: February 2011 Briefing - Orthopedics|
Reader comments on this article are listed below. Review our comments policy.